Branch retinal vein occlusion following ChAdOx1 nCoV-19 (Oxford-AstraZeneca) vaccine-Reference-Cited by-同舟云学术

Branch retinal vein occlusion following ChAdOx1 nCoV-19 (Oxford-AstraZeneca) vaccine

Published:2022-09-04 Issue: Volume: Page:112067212211246
ISSN:1120-6721
Container-title:European Journal of Ophthalmology
language:en
Short-container-title:European Journal of Ophthalmology

Author:

Karageorgiou Georgia¹²,Chronopoulou Konstantina¹²^ORCID,Georgalas Ilias¹²,Kandarakis Stylianos¹²^ORCID,Tservakis Ioannis¹²,Petrou Petros¹²^ORCID

Affiliation:

1. First Opthhalmology Department, “G.Gennimatas” Hospital, Athens, Greece

2. National and Kapodistrian University of Athens, Athens, Greece

Abstract

Purpose To present a case of branch retinal vein occlusion (BRVO) following ChAdOx1 nCoV-19 (Oxford-AstraZeneca) Vaccine. Methods Case report. Results A 60-year old otherwise healthy Caucasian male, presented to the ophthalmology emergency clinic complaining of sudden, painless vision loss in his right eye of 24 h” duration. The patient had received Vaxveria seven days prior. The clinical and fundus examination of the right eye established the diagnosis of BRVO. Conclusion The present case descibes the occurrence of BRVO soon after the vaccination with the Oxford-AstraZeneca vaccine. The close temporal relationship between the BRVO incidence and the vaccination is reinforced by the lack of othe subjective cause to justify the episode.

Publisher

SAGE Publications

Subject

Ophthalmology,General Medicine

Link

http://journals.sagepub.com/doi/pdf/10.1177/11206721221124651

Reference8 articles.

1. Central Retinal Vein Occlusion in Younger Swedish Adults: Case Reports and Review of the Literature

2. Abdelaziz M, Tripathy K, Hsu J, et al. Branch retinal vein occlusion. EyeWikki.org.

3. Emerging SARS-CoV-2 Variants and Impact in Global Vaccination Programs against SARS-CoV-2/COVID-19

4. Scruggs BA, Quist TS, Kravchuk O, et al. Branch retinal vein occlusion. https://webeye.ophth.uiowa.edu/eyeforum/cases/274-branch-retinal-vein-occlusion.htm. Cascella M, Rajnik M, Aleem A, Dulebohn SC, Di Napoli R. Features, Evaluation, and Treatment of Coronavirus (COVID-19). In: StatPearls. Treasure Island (FL): StatPearls Publishing; April 20, 2021.

5. Safety of COVID-19 vaccines administered in the EU: Should we be concerned?

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Possible association between vaccination against SARS-CoV-2 and recurrence of macular edema due to branch retinal vein occlusion: a case report;Journal of International Medical Research;2023-11

2. AZD-1222;Reactions Weekly;2023-09-23

3. Retinal Artery and Vein Occlusion Risks after Coronavirus Disease 2019 or Coronavirus Disease 2019 Vaccination;Ophthalmology;2023-09

4. Retinal Vein Occlusion Amongst People Vaccinated by mRNA- and Viral Vector- COVID-19 Vaccines: A Systematic Review;Clinical Ophthalmology;2023-09

5. Retinal Vein Occlusion after COVID-19 Vaccination—A Review;Vaccines;2023-07-26